19 May 2020 - Deborah Wilkes
Premium
Acquisitions lifted sales at Taisho Pharmaceutical’s Self-Medication division by 22.2% to JPY220 billion (USD2.04 billion) in the 12 months ended 31 March 2020.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.